Literature DB >> 2786570

Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor.

T T Kwok1, R M Sutherland.   

Abstract

Experiments were done to determine the effect of murine epidermal growth factor (EGF) on the radiation responses of the human squamous carcinoma cell line CaSki grown as an exponential monolayer culture. The radiation responses studied included recovery from potentially lethal damage (PLDR) and recovery from sublethal damage (SLDR). The presence of EGF in the cell culture either after irradiation (during the clonogenic assay period) or continuously before, during, and after irradiation enhanced the radiosensitivity of the cells and reduced their plating efficiency (PE). However, these effects were not as great when EGF was present in the cell culture only before and during irradiation. This enhancement of radiosensitivity was associated with a reduction in the shoulder region of the cell survival curves. The PE reduction and radiosensitivity enhancement were maximum with 10 ng of EGF/mL. However, EGF present continuously in the cell culture, including during the 6-hour repair period, had no effect on cellular PLDR or SLDR. The single-stranded DNA breaks present in large numbers in cells immediately after irradiation returned to control levels by 6 hours. Moreover, EGF present in cell cultures for the 48 hours before irradiation and during the 6-hour repair period had no effect on the DNA alkaline elution profiles of either control or irradiated cells. EGF did not affect the growth of unirradiated cells; however, it extended the lag-phase period for growth of irradiated cells. In summary, this EGF-induced radiosensitivity enhancement was not correlated with the effects of EGF on PE, cell growth, PLDR, or SLDR.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786570     DOI: 10.1093/jnci/81.13.1020

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.

Authors:  Takashi Yamatodani; Lars Ekblad; Elisabeth Kjellén; Anders Johnsson; Hiroyuki Mineta; Johan Wennerberg
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-24       Impact factor: 4.553

2.  Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.

Authors:  R D Christen; D K Hom; D C Porter; P A Andrews; C L MacLeod; L Hafstrom; S B Howell
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 3.  EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.

Authors:  Kyle C Cuneo; Mukesh K Nyati; Dipankar Ray; Theodore S Lawrence
Journal:  Pharmacol Ther       Date:  2015-07-21       Impact factor: 12.310

Review 4.  Signaling and drug sensitivity.

Authors:  R D Christen; S Isonishi; J A Jones; A P Jekunen; D K Hom; R Kröning; D P Gately; F B Thiebaut; G Los; S B Howell
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 5.  Cellular responses to EGFR inhibitors and their relevance to cancer therapy.

Authors:  Pinaki R Dutta; Amit Maity
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

6.  Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer.

Authors:  N Magné; J L Fischel; A Dubreuil; P Formento; S Marcié; J-L Lagrange; G Milano
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

7.  Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors.

Authors:  T T Kwok; R M Sutherland
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

8.  Enhancement of transforming growth factor-alpha synthesis in multicellular tumour spheroids of A431 squamous carcinoma cells.

Authors:  K R Laderoute; B J Murphy; S M Short; T D Grant; A M Knapp; R M Sutherland
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

9.  Enhancement of drug sensitivity of human malignancies by epidermal growth factor.

Authors:  R Kröning; J A Jones; D K Hom; C C Chuang; R Sanga; G Los; S B Howell; R D Christen
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer.

Authors:  F Miyazono; R Metzger; U Warnecke-Eberz; S E Baldus; J Brabender; E Bollschweiler; W Doerfler; R P Mueller; H P Dienes; T Aikou; A H Hoelscher; P M Schneider
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.